News
AOP Orphan Statement on SARS-CoV-2 and COVID-19
17. 3. 2020AOP Orphan hosted an Experts Press Conference at DGHO in Berlin
7. 10. 2019AOP Orphan hosted Industry Symposium at DGHO in Berlin
7. 10. 2019
Science & Innovation
From the Concept to the Drug
AOP Orphan headquarters team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
CONNECTED WORLDWIDE
Partnering
Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe. Find out more about the cooperation opportunities with AOP Orphan headquarters using the link below.